PLoS ONE
September 2007
Several clinical trials to address the efficacy of PrEP are underway, but these will take considerable time to complete and will not specifically address the potential public health benefit. We therefore developed a mathematical model of a heterosexual HIV-1 epidemic and analyzed the potential for HIV-1 prevention from PrEP under different scenarios of effectiveness, duration of use, population coverage, emergence and spread of drug resistance and increased sexual risk behavior. ... click here to read more
-- Jagged Little Pills
POZ Magazine
June 2007
Some drugs approved to treat HIV may also protect people not infected with HIV if taken before they engage in high-risk activities. Then why has it been so difficult to conduct the necessary studies to prove—or disprove—the theory?... click here to read more
-- Botswana: Botusa Conducts Truvada Clinical Trials
Mmegi/The Reporter (Gaborone)
8 May 2007
BOTUSA is conducting clinical trials to see whether Truvada, a combination of two anti-retroviral (ARV) drugs, taken daily can prevent HIV infection. The trials that are being conducted in Gaborone and Francistown, target young Batswana adults, aged 18 to 29 who are not infected by HIV... click here to read more
-- Narrative Review: Antiretroviral Therapy to Prevent the Sexual Transmission of HIV-1
Annals of Internal Medicine
17 April 2007 | Volume 146 Issue 8 | Pages 591-601
Antiretroviral therapy (ART) has prolonged and improved the lives of persons infected with HIV. Theoretically, it can also be used to prevent the transmission of HIV.... click here to read more
|
